BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 10885360)

  • 1. Melanisation of Cryptococcus neoformans in human brain tissue.
    Nosanchuk JD; Rosas AL; Lee SC; Casadevall A
    Lancet; 2000 Jun; 355(9220):2049-50. PubMed ID: 10885360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of polymerized melanin by Cryptococcus neoformans in infected rodents.
    Rosas AL; Nosanchuk JD; Feldmesser M; Cox GM; McDade HC; Casadevall A
    Infect Immun; 2000 May; 68(5):2845-53. PubMed ID: 10768981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disseminated Cryptococcus neoformans: case report and review of the literature.
    Patel NC; Ewanowski C; Kupiec-Banasikowska A; Hogan KP
    Cutis; 2009 Aug; 84(2):93-6. PubMed ID: 19746767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Melanin and its role on the virulence of Cryptococcus neoformans].
    Alp S
    Mikrobiyol Bul; 2010 Jul; 44(3):519-26. PubMed ID: 21064003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis.
    Schwarz P; Dromer F; Lortholary O; Dannaoui E
    Antimicrob Agents Chemother; 2006 Jan; 50(1):113-20. PubMed ID: 16377675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of prosthetic valve endocarditis caused by Cryptococcus neoformans var. neoformans.
    Banerjee U; Gupta K; Venugopal P
    J Med Vet Mycol; 1997; 35(2):139-41. PubMed ID: 9147274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ptilomycalin A inhibits laccase and melanization in Cryptococcus neoformans.
    Dalisay DS; Saludes JP; Molinski TF
    Bioorg Med Chem; 2011 Nov; 19(22):6654-7. PubMed ID: 21715177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioimmunotherapy is more effective than antifungal treatment in experimental cryptococcal infection.
    Bryan RA; Jiang Z; Howell RC; Morgenstern A; Bruchertseifer F; Casadevall A; Dadachova E
    J Infect Dis; 2010 Aug; 202(4):633-7. PubMed ID: 20594103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypereosinophilia in disseminated cryptococcal disease.
    Marwaha RK; Trehan A; Jayashree K; Vasishta RK
    Pediatr Infect Dis J; 1995 Dec; 14(12):1102-3. PubMed ID: 8745027
    [No Abstract]   [Full Text] [Related]  

  • 10. Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates and clinical outcomes of cryptococcal meningitis in HIV-infected patients with/without fluconazole prophylaxis.
    Manosuthi W; Sungkanuparph S; Thongyen S; Chumpathat N; Eampokalap B; Thawornwan U; Foongladda S
    J Med Assoc Thai; 2006 Jun; 89(6):795-802. PubMed ID: 16850679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catecholamine oxidative products, but not melanin, are produced by Cryptococcus neoformans during neuropathogenesis in mice.
    Liu L; Wakamatsu K; Ito S; Williamson PR
    Infect Immun; 1999 Jan; 67(1):108-12. PubMed ID: 9864203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryptococcus neoformans septicemia in an immunocompetent neonate: first case report in Thailand.
    Nakwan N; Ngerncham S; Srisuparp P; Lapphra K; Chokephaibulkit K
    Southeast Asian J Trop Med Public Health; 2008 Jul; 39(4):697-700. PubMed ID: 19058608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coumaric acid analogues inhibit growth and melanin biosynthesis in Cryptococcus neoformans and potentialize amphotericin B antifungal activity.
    Oliveira L; Ferrarini M; Dos Santos AP; Varela MT; CorrĂȘa ITS; Tempone AG; Melhem MSC; Vallim MA; Fernandes JPS; Pascon RC
    Eur J Pharm Sci; 2020 Oct; 153():105473. PubMed ID: 32693012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tzanck smear as a rapid diagnostic tool for disseminated cryptococcal infection.
    Fridlington E; Colome-Grimmer M; Kelly E; Kelly BC
    Arch Dermatol; 2006 Jan; 142(1):25-7. PubMed ID: 16415382
    [No Abstract]   [Full Text] [Related]  

  • 15. Fluconazole-resistant Cryptococcus neoformans isolated from an immunocompetent patient without prior exposure to fluconazole.
    Orni-Wasserlauf R; Izkhakov E; Siegman-Igra Y; Bash E; Polacheck I; Giladi M
    Clin Infect Dis; 1999 Dec; 29(6):1592-3. PubMed ID: 10585832
    [No Abstract]   [Full Text] [Related]  

  • 16. Susceptibility of melanized and nonmelanized Cryptococcus neoformans to the melanin-binding compounds trifluoperazine and chloroquine.
    Wang Y; Casadevall A
    Antimicrob Agents Chemother; 1996 Mar; 40(3):541-5. PubMed ID: 8851567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotypes of clinical cerebrospinal fluid Cryptococcus neoformans isolates from southern Taiwan and their in vitro susceptibilities to amphotericin B, fluconazole, and voriconazole.
    Chang WN; Huang CR; Lei CB; Lee PY; Chien CC; Chang HW; Chang CS; Lu CH
    Jpn J Infect Dis; 2004 Jun; 57(3):113-5. PubMed ID: 15218221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryptococcosis and deficiency of interleukin12r.
    Rezai MS; Khotael G; Kheirkhah M; Hedayat T; Geramishoar M; Mahjoub F
    Pediatr Infect Dis J; 2008 Jul; 27(7):673. PubMed ID: 18520441
    [No Abstract]   [Full Text] [Related]  

  • 19. The discovery of melanin production in Cryptococcus neoformans and its impact on diagnosis and the study of virulence.
    Polacheck I
    Zentralbl Bakteriol; 1991 Dec; 276(1):120-3. PubMed ID: 1789897
    [No Abstract]   [Full Text] [Related]  

  • 20. Complexing amphotericin B with gold nanoparticles improves fungal clearance from the brains of mice infected with Cryptococcal neoformans.
    Chintalacharuvu KR; Matolek ZA; Pacheco B; Carriera EM; Beenhouwer DO
    Med Mycol; 2021 Nov; 59(11):1085-1091. PubMed ID: 34332505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.